MARX Biotech Co (ROCO:7731) Total Assets: NT$832.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
8 GF Score
Price NT$4.87
! 4 Warning Signs
View Full Analysis

What is MARX Biotech Co Total Assets?

MARX Biotech Co ROCO:7731 -3.18% 8 Total Assets is NT$832.7 Mil as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

MARX Biotech Co's Total Assets for the quarter that ended in Dec. 2025 was NT$832.7 Mil.

During the past 12 months, MARX Biotech Co's average Total Assets Growth Rate was 22.20% per year. During the past 3 years, the average Total Assets Growth Rate was 119.50% per year.

During the past 6 years, MARX Biotech Co's highest 3-Year average Total Assets Growth Rate was 119.50%. The lowest was 105.80%. And the median was 112.65%.

Total Assets is connected with ROA %. MARX Biotech Co's annualized ROA % for the quarter that ended in Dec. 2025 was 20.68%. Total Assets is also linked to Revenue through Asset Turnover. MARX Biotech Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.42.

MARX Biotech Co  (ROCO:7731) Total Assets Explanation

Total Assets is connected with ROA %.

MARX Biotech Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=161.888/( (733.009+832.716)/ 2 )
=161.888/782.8625
=20.68 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

MARX Biotech Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=326.931/( (733.009+832.716)/ 2 )
=326.931/782.8625
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

MARX Biotech Co Total Assets Related Terms

MARX Biotech Co Total Assets Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Total Assets Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 91.08 103.19 394.85 731.20 832.72

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 394.85 413.46 731.20 733.01 832.72
ROCO:7731
8GF Score
MARX Biotech Co Ltd ROCO:7731
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

MARX Biotech Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=359.376+473.34
=832.7

MARX Biotech Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=359.376+473.34
=832.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$832.7 Mil mean?
MARX Biotech Co (ROCO:7731) has a Total Assets of NT$832.7 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's Total Assets too high?
MARX Biotech Co's current Total Assets is NT$832.7 Mil. Overall, MARX Biotech Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Total Assets compare to competitors?
MARX Biotech Co's Total Assets of NT$832.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Healthcare Providers & Services company?
A good Total Assets depends on the Healthcare Providers & Services industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current Total Assets is NT$832.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Total Assets of NT$832.7 Mil. The current Total Assets is NT$832.7 Mil. MARX Biotech Co's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Total Assets is NT$832.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
8GF Score

Get the complete analysis for ROCO:7731

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.87
Price